| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/04/2011 | US20110190290 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
| 08/04/2011 | US20110190283 Fab I Inhibitors |
| 08/04/2011 | US20110190273 Methods and compositions in the treatment of coronaviruses |
| 08/04/2011 | US20110190265 Methods and compositions for treating bacterial infections by inhibiting quorum sensing |
| 08/04/2011 | US20110190258 Aryl benzylamine compounds |
| 08/04/2011 | US20110190254 Cephalosporin having catechol group |
| 08/04/2011 | US20110190253 Method for treating tuberculosis |
| 08/04/2011 | US20110190245 Nanosuspension with antifungal medication to be administered via inhalation with improved impurity profile and safety |
| 08/04/2011 | US20110190241 Targeting an hiv-1 nef-host cell kinase complex |
| 08/04/2011 | US20110190239 Bmi-1 protein expression modulators |
| 08/04/2011 | US20110190236 Chemical compounds |
| 08/04/2011 | US20110190234 MYCOBACTERIUM MEMBRANE PROTEASE AS A TARGET FOR INHIBITORS OF INTRABACTERIAL pH HOMEOSTASIS |
| 08/04/2011 | US20110190233 Anionic conjugates of glycosylated bacterial metabolite |
| 08/04/2011 | US20110190226 C4'-substituted-2-deoxyadenosine analogs and methods of treating hiv |
| 08/04/2011 | US20110190203 Ophthalmic Compositions Containing A Synergistic Combination Of Two Polymers |
| 08/04/2011 | US20110190199 Combination Therapy for Tuberculosis |
| 08/04/2011 | US20110190198 Peptide sequnces, their branched form and use thereof for antimicrobial applications |
| 08/04/2011 | US20110190197 Plant derived antibiotic peptide rich in glycine |
| 08/04/2011 | US20110190195 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 08/04/2011 | US20110190194 Preparation and composition of inter-alpha proteins from blood |
| 08/04/2011 | US20110189309 Topical medicament |
| 08/04/2011 | US20110189297 Stable solid oral dosage co-formulations |
| 08/04/2011 | US20110189264 Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof |
| 08/04/2011 | US20110189263 Peptides that target dorsal root ganglion neurons |
| 08/04/2011 | US20110189262 Methods and Compositions for Reducing Systemic Toxicity of Vectors |
| 08/04/2011 | US20110189260 Use of zinc chelators to inhibit biofilm formation |
| 08/04/2011 | US20110189258 Method and compositions for inhibition of double stranded dna viruses |
| 08/04/2011 | US20110189256 Reduction of infection associated with medical device |
| 08/04/2011 | US20110189239 Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same |
| 08/04/2011 | US20110189233 Recombinant Varicella-Zoster Virus |
| 08/04/2011 | US20110189232 RECOMBINANT HUMAN PARAINFLUENZA TYPE 1 VIRUSES (HPIV1s) CONTAINING MUTATIONS IN OR DELETION OF THE C PROTEIN ARE ATTENUATED IN AFRICAN GREEN MONKEYS AND IN CILIATED HUMAN AIRWAY EPITHELIAL CELLS AND ARE POTENTIAL VACCINE CANDIDATES FOR HPIV1 |
| 08/04/2011 | US20110189231 Compositions Comprising Salmonella Porins and Uses Thereof as Adjuvants and Vaccines |
| 08/04/2011 | US20110189229 Vaccine against hpv |
| 08/04/2011 | US20110189228 Production of Heterologous Polypeptides in Microalgae, Microalgal Extracellular Bodies, Compositions, and Methods of Making and Uses Thereof |
| 08/04/2011 | US20110189227 Porcine circovirus type 2 and use thereof |
| 08/04/2011 | US20110189226 Immunization Compositions and Methods |
| 08/04/2011 | US20110189224 Pestivirus replicons providing an rna-based viral vector system |
| 08/04/2011 | US20110189223 Vaccine |
| 08/04/2011 | US20110189221 Novel antiviral compounds from marine extracts |
| 08/04/2011 | US20110189217 Methods and materials for producing immune responses against polypeptides involved in antibiotic resistance |
| 08/04/2011 | US20110189216 Compositions and Methods for the Treatment and Prophylaxis of Multiple Strains and Subtypes of HIV-1 |
| 08/04/2011 | US20110189215 Vaccine Comprising Protein NMB0964 From Neisseria Meningitidis |
| 08/04/2011 | US20110189212 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
| 08/04/2011 | US20110189208 Tb vaccine |
| 08/04/2011 | US20110189197 Antibodies Against Protective Antigen |
| 08/04/2011 | US20110189196 Metal-citrate transporter antigen from streptomyces coelicolor and uses thereof |
| 08/04/2011 | US20110189193 Cell lines and host nucleic acid sequences related to infectious disease |
| 08/04/2011 | US20110189187 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/04/2011 | US20110189183 Antibodies against candida, collections thereof and methods of use |
| 08/04/2011 | US20110189171 Recombinant antibodies for treatment of respiratory syncytial virus infections |
| 08/04/2011 | US20110189166 Methods of treating hemorheologic abnormalities in mammals |
| 08/04/2011 | US20110189160 Veterinary Topical Agent |
| 08/04/2011 | US20110189156 Method for Treating Systemic Bacterial, Fungal and Protozoan Infection |
| 08/04/2011 | US20110189155 Large Form Of Human 2',5'-Oligoadenylate Synthetase OAS3 for Preventing or Treating Infection With Positive-Sense Single-Stranded RNA Viruses |
| 08/04/2011 | US20110189146 Methods of Use of Probiotic Lactobacilli for Companion Animals |
| 08/04/2011 | US20110189144 Compositions Comprising Lactobacillus Casei for Improving Resistance to Common Infectious Diseases |
| 08/04/2011 | US20110189141 Multiple target t cell receptor |
| 08/04/2011 | US20110189133 Skin treatment compositions |
| 08/04/2011 | US20110189132 Microbial product containing multiple microorganisms |
| 08/04/2011 | US20110189129 Hepatitis c virus inhibitors |
| 08/04/2011 | US20110189128 Recombinant super-compound interferon |
| 08/04/2011 | US20110189127 Tricyclic indole derivatives and methods of use thereof |
| 08/04/2011 | US20110189125 Modulators of HSP70/DnaK Function and Methods of Use Thereof |
| 08/04/2011 | US20110189105 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 08/04/2011 | US20110189103 Aerosolized Fosfomycin/Aminoglycoside Combination for the Treatment of Bacterial Respiratory Infections |
| 08/04/2011 | US20110186457 Novel single unit carbapenem aminoglycoside formulations |
| 08/04/2011 | CA2825282A1 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same |
| 08/04/2011 | CA2788155A1 Polyheterocyclic compounds highly potent as hcv inhibitors |
| 08/04/2011 | CA2787363A1 Pyrazolopyrimidine kinase inhibitors |
| 08/04/2011 | CA2786817A1 Extracellular ifi16 as therapeutic agents |
| 08/04/2011 | CA2783518A1 Bottled ozonated water system |
| 08/03/2011 | EP2351852A1 RNA interference mediating small RNA molecules |
| 08/03/2011 | EP2351847A1 Method for producing sophorose lipid |
| 08/03/2011 | EP2351840A1 Polypeptides involved in immune response |
| 08/03/2011 | EP2351836A1 Double-stranded oligonucleotides |
| 08/03/2011 | EP2351835A1 Method for producing purified influenza virus antigen |
| 08/03/2011 | EP2351769A2 Recombinant proteins of Parapoxvirus ovis and pharmaceutical compositions therefrom |
| 08/03/2011 | EP2351767A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/03/2011 | EP2351765A2 Oligonucleotide-containing pharmacological compositions and their use |
| 08/03/2011 | EP2351764A1 Trehalose compound, method for producing same, and pharmaceutical product containing the compound |
| 08/03/2011 | EP2351754A1 Phenanthroindolizidine compound and nf b inhibitor containing same as active ingredient |
| 08/03/2011 | EP2351752A1 PYRIDINE DERIVATIVE HAVING SUBSTITUTED HETERO RING AND SUBSTITUTED y-GLUTAMYLAMINO GROUP, AND ANTI-FUNGAL AGENT COMPRISING SAME |
| 08/03/2011 | EP2351739A1 The 2-(4-substituted phenylamino) polysubstituted pyridine compounds as the inhibitors of non-nucleoside hiv reverse transcriptase, praparation methods and uses thereof |
| 08/03/2011 | EP2351731A1 A group of amino substituted benzoyl derivatives and their preparation and their use |
| 08/03/2011 | EP2351586A1 Pharmaceutical compositions of active polypeptides for enhanced pharmacological activity through oral and parenteral administration |
| 08/03/2011 | EP2351585A1 Anti-hepatitis c virus composition |
| 08/03/2011 | EP2351581A1 A vaccine composition against foot-and-mouth disease and the preparation method thereof |
| 08/03/2011 | EP2351579A1 Polypeptide vaccines for broad protection against hypervirulent meningococcal lineages |
| 08/03/2011 | EP2351578A1 Process for manufacturing vaccines |
| 08/03/2011 | EP2351572A1 Agent having anti-helicobacter pylori activity |
| 08/03/2011 | EP2351570A1 An Antibiotic/Analgesic Formulation And a Method of Making This Formulation |
| 08/03/2011 | EP2351565A1 Medicine for preventing or treating pain related to herpes zoster |
| 08/03/2011 | EP2351560A1 Treatment Of HCV infections with FTY720 |
| 08/03/2011 | EP2350277A1 Methods and compositions for prevention or treatment of rsv infection using modified duplex rna molecules |
| 08/03/2011 | EP2350120A1 Multiligand constructs |
| 08/03/2011 | EP2350119A1 Lipopeptide compounds and their use |
| 08/03/2011 | EP2350115A1 Antimicrobial compounds |
| 08/03/2011 | EP2350077A1 Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |
| 08/03/2011 | EP2350065A1 A novel polymorph of emtricitabine and a process for preparing of the same |
| 08/03/2011 | EP2350039A1 Viral polymerase inhibitors |